Telomeres, Atherosclerosis, and Human Longevity: A Causal Hypothesis
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Human telomere length, as expressed in leukocytes, is strongly fashioned by heritability.1–5 A number of genes that explain some of the inter-individual variation in leukocyte telomere length have already been identified.6–9 Leukocyte telomere length is longer in women than in men3,10,11 and in African Americans than in whites of European descent.12,13 In addition, offspring of older fathers display a longer leukocyte telomere length, a finding that may reflect longer telomeres in sperm of older men.14–17 In contrast to the male germline, telomeres in replicative somatic tissues, including the hematopoietic system, display age-dependent shortening. A shorter leukocyte telomere length is associated with aging-related diseases, principally atherosclerosis18,19 and reduced longevity.20,21 The prevailing interpretation is that a shorter leukocyte telomere length is the outcome of processes, mainly the age-dependent accruing burden of oxidative stress and inflammation22 that ultimately shorten the human lifespan. As such, leukocyte telomere length is considered to be a non-causal biomarker, ie, a telomeric “clock,” of human aging. We propose that telomere length is not only associated with atherosclerosis and longevity but is also a causal determinant of both. This hypothesis is based on a model of leukocyte telomere length dynamics (leukocyte telomere length and its attrition rate) that incorporates two key features. First, the model differentiates the findings of studies of telomere length dynamics in vitro from those in vivo. Second, the model distinguishes two phases of human leukocyte telomere length dynamics in vivo: growth and adulthood. THE TELOMERIC “CLOCK” BASED ON EXTRAPOLATIONS FROM IN VITRO STUDIES The metaphor of telomeres as a biological clock is based on research showing that somatic cell replication in culture causes telomere attrition, ultimately leading to replicative senescence (or apoptosis).23 Although senescence might be triggered by mechanisms other than critically short telomeres,24–26 the evidence is strong that the telomeric clock is a major factor in replicative senescence in vitro. Studies in cultured cells also revealed that oxidative stress heightens the loss of telomere repeats per replication, presumably due to the sensitivity of telomeres to oxidative stress.27 Leukocytes are the most frequently used somatic cells to study telomere biology in epidemiological settings. The traditional model of leukocyte telomere length dynamics, extrapolated from cultured cells to the in vivo state, is based on the premise that oxidative stress augments the loss of telomere repeats per replication of all somatic cells. However, in hematopoietic stem cells (HSCs) not only oxidative stress but also inflammation increases telomere shortening, because HSCs undergo more replication to replace leukocytes consumed by the inflammatory response. Shorter leukocyte telomere length, which reflects HSC telomere length,28,29 has therefore been attributed to a faster HSC telomere-length attrition due to a higher cumulative burden of oxidative stress and inflammation—two biological processes that are considered the hallmarks of atherosclerosis and aging.22 The concept of leukocyte telomere length as a biomarker of aging entails the premise that at birth, if not at conception, all individuals have a biological age—a telomeric clock time—of zero. In newborns, however, we see great variation in leukocyte telomere length, with values ranging from 8 to 11 kb or more.30,31 This variation among newborns exceeds the total average leukocyte telomere length shortening throughout the adult life course (20–90 years) estimated at <2.0 kb, assuming an average leukocyte telomere length attrition rate of 25–30 bp/year.32 Thus, the use of leukocyte telomere length as a biomarker of aging in vivo should account for not only leukocyte telomere length attrition but also leukocyte telomere length at birth for each individual, an important point often overlooked. TELOMERE DYNAMICS IN VIVO IN THE HEMATOPOIETIC SYSTEM Cultured cells typically display exponential proliferation, whereby one cell divides into two daughter cells, ie, symmetric replication. However, in vivo, HSCs experience both symmetric replication to two daughter HSCs and asymmetric replication to a daughter hematopoietic progenitor cell (HPC) and a daughter HSC.33 Symmetric replication, as in cultured cells, serves to expand exponentially the HSC reservoir during growth. It takes, for example, four cycles of symmetric HSC replication to generate 16 HSCs [2-4-8-16]. In contrast, asymmetric HSC replication during growth, which linearly expands the HPC pool and ultimately the peripheral blood cell mass, takes 16 cycles to generate 16 HPCs. Therefore, during growth, expansion of the HPC pool in tandem with the growing soma requires far more replication and more telomere attrition than the expansion of the HSC reservoir.29,34 Accordingly, the expansion of the HPC pool is pro
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 1×
“expressed in diminished ability of stem cells, including HsCs, to maintain tissue repair.(25,48,49) thus, although the conventional model focuses on leukocyte telomere length as an index of”
BackgroundTelomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319 · cited 1×
“Finally, although oxidative stress might augment leukocyte telomere length attrition to some extent, in genetically engineered mice with ablated telomerase, short telomeres impair mitochondrial biogenesis so as to increase the output of reactive oxygen species and compromise organ function.(43) thus, the cause-and-eff…”
BackgroundTelomere loss: mitotic clock or genetic time bomb?
Harley, C. B. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90018-7 · Cited by 1,139
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
Haycock, P. C., Heydon, E. E., Kaptoge, S., Butterworth, A. S., Thompson, A., & Willeit, P. (2014) · BMJ · doi:10.1136/bmj.g4227 · Cited by 856
Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation
Fumagalli, M., Rossiello, F., Clerici, M., Barozzi, S., Cittaro, D., Kaplunov, J. M., Bucci, G., Dobreva, M., Matti, V., Beausejour, C. M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2466 · Cited by 851
Telomeres shorten at equivalent rates in somatic tissues of adults
Daniali, L., Benetos, A., Susser, E., Kark, J. D., Labat, C., Kimura, M., Desai, K. K., Granick, M., & Aviv, A. (2013) · Nature Communications · doi:10.1038/ncomms2602 · Cited by 601 · cited 3×
“replication and more telomere attrition than the expansion of the HsC reservoir.(29,34) Accordingly, the expansion of the HpC pool”
BackgroundSelf-citationTelomere Length in the Newborn
Okuda, K., Bardeguez, A., Gardner, J. P., Rodriguez, P., Ganesh, V., Kimura, M., Skurnick, J., Awad, G., & Aviv, A. (2002) · Pediatric Research · doi:10.1203/00006450-200209000-00012 · Cited by 507 · cited 1×
“in newborns, however, we see great variation in leukocyte telomere length, with values ranging from 8 to 11 kb or more.(30,31) this variation among newborns exceeds the total average leukocyte telomere length shortening throughout the adult life course (20–90 years) estimated at <2.”
BackgroundSelf-citationGomes, N. M. V., Ryder, O. A., Houck, M. L., Charter, S. J., Walker, W., Forsyth, N. R., Austad, S. N., Venditti, C., Pagel, M., Shay, J. W., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00718.x · Cited by 464
Broer, L., Codd, V., Nyholt, D. R., Deelen, J., Mangino, M., Willemsen, G., Albrecht, E., Amin, N., Beekman, M., de Geus, E. J. C., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.303 · Cited by 450
Common variants near TERC are associated with mean telomere length
Wellcome Trust Case Control Consortium, Codd, V., Mangino, M., van der Harst, P., Braund, P. S., Kaiser, M., Beveridge, A. J., Rafelt, S., Moore, J., Nelson, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.532 · Cited by 344
Cited by
Puterman, E., Gemmill, A., Karasek, D., Weir, D., Adler, N. E., Prather, A. A., & Epel, E. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525602113 · Cited by 165
Questioning causal involvement of telomeres in aging
Simons, M. J. P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.08.002 · Cited by 108
Nutrigenomics at the Interface of Aging, Lifespan, and Cancer Prevention
Riscuta, G. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.235119 · Cited by 37
Telomeres and telomerase in risk assessment of cardiovascular diseases
Boniewska-Bernacka, E., Pańczyszyn, A., & Klinger, M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112361 · Cited by 31
Metadata
- Authors
- Aviv, A., Kark, J. D., & Susser, E.
- Venue
- Epidemiology
- Published
- 2015-05
- Volume
- 26
- Issue
- 3
- Pages
- 295-299
- ISSN
- 1044-3983 (ISSN-L)
- OpenAlex
- W2314849357
- Cited by
- 61
- References
- 16
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomeres, Atherosclerosis, and Human Longevity: A Causal Hypothesis. https://app.cochat.ai/papers/10.1097/ede.0000000000000280
- The paper
- Aviv, A., Kark, J. D., & Susser, E. (2015). Telomeres, Atherosclerosis, and Human Longevity: A Causal Hypothesis. Epidemiology. https://doi.org/10.1097/ede.0000000000000280
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.